Ocrevus Zunovo (ocrelizumab/hyaluronidase-ocsq) can cause mild to serious side effects. More common side effects include respiratory infections (upper and lower). If ...

Nexavar (sorafenib) can cause side effects that range from mild to serious. More common side effects include decreased appetite and diarrhea. If side effects from Nexavar become difficult to tolerate, ...

Ozempic, Wegovy and other GLP-1 medications are popular but can cause unwanted health concerns.

As with other drugs, Braftovi (encorafenib) can cause side effects that can be mild or serious. Side effects of Braftovi may vary depending on the condition the drug is being used to treat. For ...

This medication is a beneficial addition to your prostate cancer treatment plan — but it doesn’t come without risks. Here’s how to stay ahead of potential side effects. If you’ve been diagnosed with ...

Crohn’s disease is a condition that causes inflammation and irritation in your digestive tract. It is a kind of inflammatory bowel disease (IBD). Common symptoms include diarrhea, pain in your ...

Trodelvy shows effectiveness in treating metastatic triple-negative breast cancer, supported by real-world data. Common side effects include neutropenia, anemia, and fatigue, but are generally ...

Ozempic (semaglutide) is a prescription medication that's approved by the US Food and Drug Administration (FDA) for both managing blood sugar in adults with type 2 diabetes and for reducing the risk ...

Benadryl (diphenhydramine) is an over-the-counter medication for allergies and cold symptoms. Common side effects include sleepiness, dizziness, dry mouth, and indigestion. Serious side effects are ...

Dr. Kevin Kalinsky discusses common side effects associated with the FDA-approved combination of Enhertu and Perjeta for breast cancer. Antibody-drug conjugates (ADCs) are rapidly changing the ...

Medically reviewed by Patricia Mikula, PharmD Key Takeaways Most side effects of ginseng are mild and temporary, and serious ...

“Semaglutide is very effective for weight loss,” says Dr. Saunders. In fact, a 2021 phase 3 clinical trial found that 2.4 ...